Westpac Banking Corp
WBC
CommBank
CBA
Fortescue Ltd
FMG
Rio Tinto Ltd
RIO
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
ZLD Zelira Therapeutics Ltd
- 0.620
- +0.050+8.77%
20min DelayNot Open Dec 27 14:45 AET
7.04MMarket Cap-0.19P/E (Static)
0.620High0.600Low1.89KVolume0.600Open0.570Pre Close1.15KTurnover1.09052wk High0.03%Turnover Ratio11.35MShares0.28052wk Low-3.223EPS TTM3.65MFloat Cap5625176.649Historical HighLossP/E (Static)5.89MShs Float0.280Historical Low-3.223EPS LYR3.51%Amplitude--Dividend TTM-1.56P/B1Lot Size--Div YieldTTM
About Zelira Therapeutics Ltd Company
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.
Company Profile
SymbolZLD
Company NameZelira Therapeutics Ltd
Founded2003
MarketASX
Employees8
Fiscal Year Ends06-30
Address101 St George’s Terrace Level 3
CityPerth
CountryAustralia
Zip Code6000
Phone+61 865580886
Websitehttps://www.zeliratx.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Level 17, 221 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000
1300 850 505
Company Executives
- Name
- Position
- Salary
- Osagie Imasogie
- Non-Executive Chairman,Non-Executive Director
- --
- Timothy (Tim) Ryan Slate
- Company Secretary,Non-Executive Director
- --
- Oludare Odumosu
- Managing Director
- --
- Greg Blake
- Executive Director
- --
- Donna Gentile O'Donnell
- Non-Executive Director
- --